A Three-Part, Randomised Study to Investigate the Safety, Tolerability, Pharmacokinetics and Mode of Action of BC 007, Neutraliser of Pathogenic Autoantibodies Against G-Protein Coupled Receptors in Healthy, Young and Elderly Subjects

ConclusionBC 007 is demonstrated to be safe and well tolerated. BC 007 neutralisedfGPCR-AAb, showing a trend for a dose-response relationship in elderly healthy butfGPCR-AAb-positive subjects.ClinicalTrials.gov Registration NumberNCT02955420.

http://link.springer.com/10.1007/s40261-020-00903-9

Source: Clinical Drug Investigation - March 27, 2020 Category: Drugs & Pharmacology Source Type: research